<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Brakke Consulting&#x306E;&#x30A6;&#x30A7;&#x30D6;&#x30B5;&#x30A4;&#x30C8;</provider_name><provider_url>https://brakkeconsulting.com/ja</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="9PHMCgr4t1"&gt;&lt;a href="https://brakkeconsulting.com/ja/brakke-viewpoint-october-4-2024/"&gt;&#x30D6;&#x30E9;&#x30C3;&#x30B1;&#x5C55;&#x671B;&#x53F0; 2024 &#x5E74; 10 &#x6708; 4 &#x65E5;&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/ja/brakke-viewpoint-october-4-2024/embed/#?secret=9PHMCgr4t1" width="600" height="338" title="&#x300C;Brakke Viewpoint 2024 &#x5E74; 10 &#x6708; 4 &#x65E5;&#x300D; &#x2014; Brakke Consulting Website" data-secret="9PHMCgr4t1" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>October has always been one of my favorite months of the year.&#xA0; Great weather, great sports, great activities for sportsmen &#x2013; I could go on.&#xA0; But business-wise, I always felt that October was like the start of the last lap around the track in a mile-long race.&#xA0; I had three quarters (or laps) behind me, and I had to finish the year strong&#x2026;and had to finish the budget for the next year. This connection between budgeting and innovation came to mind after reviewing this week&#x2019;s developments in the newsletter. Several companies announced the approval of important and popular generic products for companion animals and livestock.&#xA0; And the FDA&#x2019;s CVM announced they are restructuring their ONADE organization into two groups, one focused on generic drugs and the other on new, original drugs.&#xA0; I have not yet been able to find out what drove this change, but it would not be a surprise that a big driver was the high volume of generic drugs going through the approval process.&#xA0; Maybe it was a low volume of new drug applications. I know that innovations in our industry are coming to market &#x2013; Elanco&#x2019;s dermatology product Zenrelia was just approved, and they expect approval of their parasiticide Credelio Quattro still this year.&#xA0; But I often feel, especially on the livestock side, there should beView Full Post;</description></oembed>
